Introduction

This chapter covers various articles and studies related to diabetes, including the Select Trial on Sumaglotide and Cardiovascular Outcomes, the economic costs of diabetes in the US in 2022, intensive lifestyle intervention for remission of early type 2 diabetes, CGM efficacy and safety in type 2 diabetes, and a presidential advisory on Cardiovascular Kidney Metabolic Health.